UBS initiates Celgene Corporation(NASDAQ:CELG) with a Buy and price target of $140. Robust top-line growth has become a rarity in large-cap biotech, and against that backdrop, Celgene has and should continue to stand out
NewLink Genetics Corp (NASDAQ:NLNK): Members At Traders Insights Are Up A Whopping 17% in Just 24-Hour
Are you a swing trade and want to make quick return with favorable risk/reward ratio. Then, Traders Insights could be the right choice for you. We at Traders Insights provide daily swing trading alerts
Puma Biotechnology Inc (NASDAQ:PBYI), Shake Shack Inc (NYSE:SHAK): What Analysts Are Saying After Today’s News?
Puma Biotechnology Inc(NASDAQ:PBYI). target lowered to $17 at RBC Capital Mkts; APHINITY hits; extended adjuvant is done; 3rd-line metastatic Phase III data 1H17 (38.05) RBC Capital Mkts lowers their PBYI tgt to $17 from $48.
Ocular Therapeutix Inc(NASDAQ:OCUL) receives CRL from the FDA regarding its NDA for DEXTENZA 0.4 mg, for intracanalicular use in the treatment of ocular pain occurring after ophthalmic surgery (5.17) The concerns raised by the FDA pertain